Vapir Enterprises (OTCQB: VAPI)

 Fact Sheet

Vapir Enterprises Inc. d/b/a Vapir Inc. (VAPI) invents, develops, and manufactures revolutionary, state-of-the-art, and user friendly medical-grade digital vaporization devices in both desktop and portable varieties. VAPI vaporizers extract active ingredients from source material using a unique and proprietary process while offering precise temperature control, LCD displays, elegant design, and premium materials for a truly superior vapor experience. VAPI technology can be customized to serve a variety of medical and non-medical applications, ranging from smoking cessation, aroma therapy, and medication delivery. The Company has delivered more than 400 thousand items to date

Find a broker to begin trading VAPI now

Investment HighlightsValue Proposition
Company Name Vapir Enterprises
Market/Symbol OTCQB: VAPI
Recent Price
Market Cap $4.48M
Avg. Daily Vol. (3m) 2,252
Price/Book N/A
Price/Cash Flow N/A
As of Sep. 23, 2016
*Source: QuoteMedia


Begin trading VAPI

 Find Broker

Recent Company Videos


Vapir: Sales Expected to Accelerate for Leading Vaporizer Company

Oct. 26, 2015

Vapir Enterprises (OTCQB: VAPI) presents at the October 2015 RedChip Global Online Microcap Conference. Learn more at: ...


Investment Highlights


  • Industry grew 23% in 2014
  • Open system device sales (VAPI segment) grew at 2x industry rate
  • Open system devices currently account for 60% of industry sales

  • 400 thousand items sold to date globally
  • Four products commercially available
  • Expanding product portfolio

Recently launched new, state-of-the-art, ultra-portable Prima vaporizer

Projecting $3.0 million in revenue in 2015; expected to grow to $9.0 million in revenue in 2017

  • Four issued patents; two patents pending
  • Eight trademarks covering design, innovation, and branding

  • VAPI patented technology has multiple consumer and pharmaceutical applications and possibilities
  • Efficient and effective delivery system includes dosage control and safety factors that position VAPI technology and its application ahead of its competitors

Value Proposition


The U.S. electronic vaporizer market is now estimated at $2.5 billion and growing according to analysts at Wells Fargo Securities. While the overall market grew at 23% in 2014, open system sales, the segment occupied by VAPI’s products, is estimated to be growing twice as fast as the overall vapor category, currently accounting for 60% of all U.S. vaporizer sales. With a track record of success that includes hundreds of thousands of units sold and a competitive advantage that overcomes the shortcomings of currently known alternatives, VAPI is well-positioned to capitalize on industry dynamics. The recent product launch of its new ultra-portable Prima vaporizer, along with a focus on marketing, geographic expansion, and higher-margin direct sales, is expected to drive double-digit top-line growth and near-term profitability.

Vapir Enterprises Latest News


Ask the CEO



VAPI Research

For over two decades RedChip Companies has been writing research on small-cap stocks. RedChip was the first to put independent research coverage on Starbucks in 1992. Our research analysts, CFAs, include financial models and target prices based on industry competitors. Our analysts cover dozens of stocks with a focus on healthcare, technology, social media, and consumer goods.

RedChip Companies research reports are distributed to 60,000 opt-in retail, institutional, and accredited investors.

RedChip Direct Investment Opportunities For Private and Public Companies

Receive VAPI Email Alerts

*By entering your information you agree to our privacy policy.


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President The NASDAQ Stock Market